 |
|
Unreported Financial Disclosures in a Study of Migraine and Cardiovascular Disease—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: The letter from Dr Kurth and colleagues is an example of how authors may misunderstand the JAMA policies for reporting conflicts of interest and financial disclosures1 and why we published an updated clarification and enhanced the policies.2 The authors believe they have no financial interests, relationships, or affiliations that would be relevant to their study describing a "biological link between migraine and cardiovascular disease." However, since the late 1980s,3 our policy has required complete disclosure of all financial interests and relationships and all affiliations relevant to the subject matter discussed in the article. In this case, financial interests and relationships with manufacturers of products that are used in the management of migraine or cardiovascular disease certainly are relevant and should be disclosed, as the authors have now reported.
As recently described, JAMA now will require that authors include disclosure of all potential conflicts of interest in the manuscript . . . [Full Text of this Article]
Catherine D. DeAngelis, MD, MPH
Editor in Chief, JAMA
Phil B. Fontanarosa, MD, MBA
Executive Deputy Editor, JAMA
RELATED ARTICLES
Unreported Financial Disclosures in a Study of Migraine and Cardiovascular Disease
Tobias Kurth, J. Michael Gaziano, Nancy R. Cook, Giancarlo Logroscino, Hans-Christoph Diener, and Julie E. Buring
JAMA. 2006;296(6):653-654.
EXTRACT
| FULL TEXT
Migraine and Risk of Cardiovascular Disease in Women
Tobias Kurth, J. Michael Gaziano, Nancy R. Cook, Giancarlo Logroscino, Hans-Christoph Diener, and Julie E. Buring
JAMA. 2006;296(3):283-291.
ABSTRACT
| FULL TEXT
|
